CBD Global Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBDNF research report →
About the company
CBD Global Sciences Inc. operates within the cannabidiol (CBD) sector, handling the cultivation, processing, and manufacturing of CBD products. Its offerings include biomass, various CBD oils, and other CBD-based items, which are marketed under the Aethics, CannaOil, and Strasburg Pharms brands.
- CEO
- Brad Wyatt
- IPO
- 2021
- HQ
- Lakewood, CO, US
Price Chart
- Market Cap
- $2.07M
- P/E
- -0.20
- P/S
- 9.39
- P/B
- -0.67
- EV/EBITDA
- -0.85
- Div Yield
- 0.00%
- Gross Margin
- 24.56%
- Op Margin
- -1641.21%
- Net Margin
- -3469.40%
- ROE
- 116.17%
- ROIC
- -391.67%
- Revenue
- $166.95K · -45.33%
- Net Income
- $-5,252,701 · 41.16%
- EPS
- $-0.15 · 46.43%
- Op Income
- $-2,739,944
- FCF YoY
- 14.79%
- 52W High
- $0.12
- 52W Low
- $0.02
- 50D MA
- $0.06
- 200D MA
- $0.07
- Beta
- 0.43
- Avg Volume
- 13.90K
Get TickerSpark's AI analysis on CBDNF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our CBDNF coverage
Recent articles, reports, and earnings notes.
No research on CBDNF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CBDNF report →Similar companies
Peers in the same neighborhood.